Management of hot flushes without oestrogen

Journal of the British Menopause Society

Volumn 8, Issue 4, 2002, Pages 147-151

  Albertazzi, Paola ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Alternative treatment; Herbalism; Hot flushes; Phytoestrogens; Progesterone

Indexed keywords

4 AMINOBUTYRIC ACID DERIVATIVE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DOPAMINE RECEPTOR BLOCKING AGENT; ESTROGEN; FLUOXETINE; GABAPENTIN; GESTAGEN; GINSENG EXTRACT; HERBACEOUS AGENT; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MIRTAZAPINE; NEUROLEPTIC AGENT; PAROXETINE; PHYTOESTROGEN; PLACEBO; PRIMROSE OIL; PROGESTERONE; PROLACTIN; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TRAZODONE; UNINDEXED DRUG; VENLAFAXINE; VERALIPRIDE;

APPETITE DISORDER; BEHAVIOR THERAPY; BREAST CANCER; CHINESE MEDICINE; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; CONSULTATION; DEPRESSION; DERMATITIS; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ESTROGEN THERAPY; EXERCISE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSE; MENSTRUATION; NAUSEA; PATHOGENESIS; POSTMENOPAUSE; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; SLEEP DISORDER; SYMPTOM; VITAMIN SUPPLEMENTATION; XEROSTOMIA;

EID: 0036946560     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218002100321848     Document Type: Review

References (61)

1. Casper RF, Graves GR, Reid RL. Objective measurement of hot flushes associated with the premenstrual syndrome. Fertil Steril 1987; 2: 341-344.
2. Gjerdingen DK, Froberg DG, Chaloner KM, McGovern PM. Changes in women's physical health during the first postpartum year. Arch Fam Med 1993; 2: 2777-2783.
3. Gassin AL. Fortification and the European consumer: Consumer awareness and attitude to food fortification. Scand J Nutrit 1999; 43: 122-124.
4. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994; 309: 107-111.
5. Albertazzi P, Steel SA, Clifford E, Bottazzi M. Attitudes towards and use of dietary supplementation in a sample of postmenopausal women. Climacteric 2002; 5: 1-5.
6. Meydani M, Meydani M. Nutrition interventions in aging and age-associated disease. Proc Nutr Soc 2002; 2: 165-171.
7. Barton DL, Loprinzi CL, Quella SK et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998; 16: 495-500.
8. Chenoy R, Hussain S, Tayob Y, et al. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 1994; 308: 501-3.
9. Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: A double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 1999; 19: 89-99.
10. Zell B, Hirata J, Marcus A, et al. Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners. Menopause 2000; 2; 129-134.
11. Nagata C, Takatsuka N, Kawakami N. Soy product intake and hot flushes in Japanese women: Results from a community based prospective study. Am J Epidemiol 2001; 153: 790-793.
12. Ernst E. Herbalism and the menopause. J Br Meno Soc 2002; 8: 72-74.
13. Ernst E. Herbal remedies as a treatment of some frequent symptoms during menopause. J Br Meno Soc 1999; 5: 117-120.
14. Mackey R, Eden J. Phytoestrogens. J Br Meno Soc 1998; 4: 18-23.
15. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6-11.
16. Balk JL, Whiteside DA, Naus G, et al. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig 2002; 9: 238-242.
17. Marwick C. Growing use of medicinal botanical forces assessment by drug regulators. JAMA 1995; 273: 607-609.
18. Albertazzi P, Steel SA, Clifford E, Bottazzi M. Attitudes towards and use of dietary supplementation in a simple of postmenopausal women. Climacteric 2002; 5: 1-5.
19. Vitamins and mineral supplements. Mintel market intelligence. Standard Series. Mintel London UK. May 2001: 1-37.
20. Kessler DA. Cancer and herbs. N Eng J Med 2000; 342: 1742-1743.
21. Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus infected patients. Arch Intern Med 1991; 151: 2281-2288.
22. D'Arcy PF. Adverse reactions and interactions with herbal medicine, I: Adverse reactions. Adverse Drug React Toxicol Rev 1991; 10: 189-208.
23. Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St. John's wort. Lancet 2000; 355: 547-548.
24. Haller C, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833-8.
25. Johnson EB, Muto M, Yanushpolsky EH, Mutter GL. Phytoestrogen supplementation and endometrial cancer. Obstet Gynecol 2001; 98: 947-950.
26. Schiff I, Tulchinsky D, Cramer D, Rayan KJ. Oral medroxyprogesterone in the treatment of postmenopausal symptom. JAMA 1980; 244: 1443-1445.
27. Aslaksen K, Frankendal B. Effect of oral medroxyprogesterone acetate on menopausal symptoms in patients with endometrial carcinoma. Acta Obstet Gynecol Scand. 1982; 61: 423-428.
28. Bertelli G, Venturini M, Del Mastro L, et al. Intramuscular depot medroxyprogesterone versus oral mergestrol for the control of postmenopausal hot flushes in breast cancer patients: A randomized study. Ann Oncol 2002; 13: 883-888.
29. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flushes. N Engl J Med 1994; 331: 347-352.
30. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
31. Peterson CM. Progestogens, progesterone antagonists, progesterone and androgens: Synthesis, classification and uses. Clin Obstet Gynecol 1995; 38: 813-820.
32. How Biogest works, http://www.biogest.net/how_biogest_works_fs.htm
33. Dewick PM. Pharmaceutical steroids and their production for hormone replacement therapy. J Br Meno Soc 1999; 5: 12-22.
34. Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999; 94: 225-8.
35. Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001; 4: 144-150.
36. Berendsen HHG. Hot flushes and serotonin. J Br Meno Soc 2002; 8: 30-34.
37. Berendsen HH, Weekers AH, Kloosterboer HJ. Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats. Eur J Pharmacol 2001; 419: 47-54.
38. Pandya KJ, Raubertas RF, Flynn PJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: A University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 2000; 132: 788-793.
39. David A, Don R, Tajchner G, Weissglas L. Veralipride: Alternative antidopaminergic treatment for menopausal symptoms. Am J Obstet Gynecol 1988; 158: 1107-1111.
40. Verbeke K, Dhont K, Vandekerckhove D. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women. Maturitas 1988; 10: 225-230.
41. Guttuso TJ Jr. Gabapentin's effects on hot flashes and hypothermia. Neurology 2000; 54: 2161-2163.
42. Berendsen HH. The role of serotonin in hot flushes. Maturitas 2000; 36: 155-164.
43. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet 2000; 356: 2059-2063.
44. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20: 1578-1583.
45. Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002; 4: 337-345.
46. Pansini F, Albertazzi P, Bonaccorsi G, et al. Trazodone: A non-hormonal alternative for neurovegetative climacteric symptoms. Clin Exp Obstet Gynecol 1995; 22: 341-344.
47. Waldinger MD, Berendsen HH, Schweitzer DH. Treatment of hot flushes with mirtazapine: Four case reports. Maturitas 2000; 36: 165-168.
48. Coope J, Williams S, Patterson JS. A study of the effectiveness of propranolol in menopausal hot flushes. Br J Obstet Gynaecol 1978; 6: 472-475.
49. Alcoff JM, Campbell D, Tribble D, et al. Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms. Clin Ther 1981; 5: 356-364.
50. Shaw CR. The perimenopausal hot flush: Epidemiology, physiology and treatment. Nurse Pract 1997; 55: 61-66.
51. Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990; 69: 409-412.
52. Slaven L, Lee C. Mood and symptom reporting among middle-aged women: The relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychol 1997; 16: 203-208.
53. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998; 29: 139-46.
54. Stevenson DW, Delprato DJ. Multiple component self-control program for menopausal hot flashes. J Behav Ther Exp Psychiatry 1983; 2: 137-140.
55. Wijma K, Melin A, Nedstrand E, Hammar M. Treatment of menopausal symptoms with applied relaxation: A pilot study. J Behav Ther Exp Psychiatry 1997; 28: 251-261.
56. Freedman RR, Woodward S. Behavioural treatment of menopausal hot flushes: Evaluation of ambulatory monitoring. Am J Obstet Gynecol 1992; 167: 436-439.
57. Hunter MS. A treatment option for menopausal hot flushes: Cognitive relaxation therapy. Europ Meno J 1995; 2: 16-17.
58. Carpenter JS, Wells N, Lambert B, et al. A pilot study of magnetic therapy for hot flushes after breast cancer. Cancer Nurs 2002; 25: 104-109.
59. Porzio G, Trapasso T, Martelli, S et al. Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen. Tumori 2002; 88: 128-130.
60. Dong H, Ludicke F, Comte I, et al. An exploratory pilot study of acupuncture on the quality of life and reproductive hormone secretion in menopausal women. J Altern Complement Med 2001, 7: 651-658.
61. Shulman LP, Yankov V, Uhl K. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestreltransdermal system and its effects on vasomotor symptoms and endometrial safety inpostmenopausal women: The results of two multicenter, double-blind, randomized, controlled Menopause 2002, 3: 195-207.